FHTX vs PARA · rev $19.3M vs rev $12.2M
Foghorn Therapeutics Inc (FHTX) versus PARA (PARA) — a side-by-side from cached financials, not a winner call.
Foghorn Therapeutics Inc (FHTX) is a biotechnology company listed on NASDAQ.
PARA (PARA) common stock.
Latest reported FHTX revenue for 2026-06-30 was $19.3M. Net income was -$27.1M. FHTX currently screens at market cap $237.8M.
Latest reported PARA revenue for 2025-12-31 was $12.2M. Net income was -$22.5M. Revenue was up 168.6% from 2024-12-31 to 2025-12-31. PARA currently screens at market cap $0.
FHTX currently screens at market cap $237.8M. PARA currently screens at market cap $0.
Not investment advice. Open the FHTX and PARA stock pages for the full models.
Not investment advice.